Cargando…
Label-free quantitative proteomics of CD133-positive liver cancer stem cells
BACKGROUND: CD133-positive liver cancer stem cells, which are characterized by their resistance to conventional chemotherapy and their tumor initiation ability at limited dilutions, have been recognized as a critical target in liver cancer therapeutics. In the current work, we developed a label-free...
Autores principales: | Tsai, Sheng-Ta, Tsou, Chih-Chiang, Mao, Wan-Yu, Chang, Wei-Chao, Han, Hsin-Ying, Hsu, Wen-Lian, Li, Chung-Leung, Shen, Chia-Ning, Chen, Chung-Hsuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576254/ https://www.ncbi.nlm.nih.gov/pubmed/23170877 http://dx.doi.org/10.1186/1477-5956-10-69 |
Ejemplares similares
-
IDEAL-Q, an Automated Tool for Label-free Quantitation Analysis Using an Efficient Peptide Alignment Approach and Spectral Data Validation
por: Tsou, Chih-Chiang, et al.
Publicado: (2010) -
Large-scale determination of absolute phosphorylation stoichiometries in human cells by motif-targeting quantitative proteomics
por: Tsai, Chia-Feng, et al.
Publicado: (2015) -
An Informatics-assisted Label-free Approach for Personalized Tissue Membrane Proteomics: Case Study on Colorectal Cancer
por: Han, Chia-Li, et al.
Publicado: (2011) -
Comparative Proteomic Analysis of Proteins Involved in the Tumorigenic Process of Seminal Vesicle Carcinoma in Transgenic Mice
por: Chang, Wei-Chao, et al.
Publicado: (2010) -
Benchmarking Quantitative Performance in Label-Free
Proteomics
por: Dowell, James A., et al.
Publicado: (2021)